November 1, 2024By Sarah Azarchi, MDEstrogen in SchizophreniaEstrogen therapy may improve schizophrenia symptoms in women, highlighting its potential role as an adjunctive treatment.
November 1, 2024By Alvin Marquez, MDOverdiagnosis of ADHDA recent study reveals the limitations of ADHD screening tools, highlighting the risks of overdiagnosis in adults based on self-reports.
November 1, 2024By Alex Evans, PharmD, MBA.Lithium, Valproate Have Low (and Similar) Risk of Kidney InjuryResearch explores the kidney injury risks associated with lithium compared to valproate, revealing unexpected findings.
October 1, 2024Listen to The Carlat Psychiatry Report, October 2024, Volume 22, Issue 10, “Addiction”
September 26, 2024By José S. Sanchez-Cruz, MDEnhancing PTSD Therapy With Aerobic Exercise: A New Approach
October 18, 2024By Jason Mallo, DOKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything
General PsychiatryKarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change EverythingRead More
General PsychiatryPsychopharm Secrets: What Patients Won’t Tell YouHow to assess med response when the patient reports is a poor guide: long-term mood stabilizers, sleep meds, and rapid cycling.Listen now
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024
How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered PractitionersMay 24, 2024